New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareGHRP-2 vs Bronchogen

GHRP-2 vs Bronchogen

Side-by-side comparison of key properties, dosing, and research.

Growth Hormone Peptides
GHRP-2
Anti-Aging & Longevity
Bronchogen
Summary
GHRP-2 is a potent synthetic hexapeptide that stimulates growth hormone release by activating ghrelin receptors in the pituitary and hypothalamus. It produces one of the strongest GH pulses among GHRPs, though unlike Ipamorelin it does cause modest increases in cortisol and prolactin.
Bronchogen is a tetrapeptide bioregulator (Ala-Glu-Asp-Leu) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is a tissue-specific bioregulator designed for the bronchi and lungs, promoting normalization of bronchial epithelial cell function. Research suggests benefits for respiratory health, protection against pulmonary aging, and support for bronchopulmonary conditions.
Half-Life
15–60 minutes
Short (minutes to hours); bioregulator effects are gene-mediated and longer lasting
Admin Route
SubQ, Intranasal
SubQ, Oral
Research
Typical Dose
100–300 mcg
10 mg per day
Frequency
2–3 times daily
Daily for 10–30 days
Key Benefits
  • Strong GH pulse stimulation
  • Increased IGF-1 levels
  • Enhanced muscle growth and recovery
  • Improved fat metabolism
  • Better sleep quality
  • Increased bone density
  • Enhanced appetite (less pronounced than GHRP-6)
  • Anti-aging effects via GH axis optimization
  • Tissue-specific support for bronchial and lung health
  • Promotes normalization of bronchial epithelial cell function
  • Potential benefits in chronic bronchitis and COPD support
  • Anti-aging effects on pulmonary tissue
  • May reduce frequency of respiratory infections
  • Supports lung function preservation with aging
  • Compatible with other Khavinson bioregulator peptides
Side Effects
  • Increased appetite
  • Water retention
  • Elevated cortisol (modest)
  • Elevated prolactin (modest)
  • +2 more
  • Generally well tolerated in research studies
  • Mild local reactions at injection site (if injected)
  • No significant systemic side effects reported at standard doses
Stacks With